Vertex Pharmaceuticals Inc. 10-K and 10-Q filings
Vertex Pharmaceuticals Inc. has 16 annual reports and 51 quarterly reports with XBRL financial data on SEC EDGAR, filed between May 3, 2010 and Nov 3, 2026. Each link opens the filing's index page on sec.gov, where you can read the full document.
| Filed | Form | Accession number | Document |
|---|---|---|---|
| Nov 3, 2026 | 10-Q | 0000875320-26-000291 | View on SEC EDGAR |
| Aug 4, 2026 | 10-Q | 0000875320-26-000259 | View on SEC EDGAR |
| May 5, 2026 | 10-Q | 0000875320-26-000173 | View on SEC EDGAR |
| Feb 13, 2026 | 10-K | 0000875320-26-000056 | View on SEC EDGAR |
| Nov 4, 2025 | 10-Q | 0000875320-25-000232 | View on SEC EDGAR |
| Aug 5, 2025 | 10-Q | 0000875320-25-000216 | View on SEC EDGAR |
| May 6, 2025 | 10-Q | 0000875320-25-000192 | View on SEC EDGAR |
| Feb 13, 2025 | 10-K | 0000875320-25-000053 | View on SEC EDGAR |
| Nov 5, 2024 | 10-Q | 0000875320-24-000223 | View on SEC EDGAR |
| Aug 2, 2024 | 10-Q | 0000875320-24-000198 | View on SEC EDGAR |
| May 7, 2024 | 10-Q | 0000875320-24-000139 | View on SEC EDGAR |
| Feb 15, 2024 | 10-K | 0000875320-24-000062 | View on SEC EDGAR |
| Nov 7, 2023 | 10-Q | 0000875320-23-000031 | View on SEC EDGAR |
| Aug 2, 2023 | 10-Q | 0000875320-23-000021 | View on SEC EDGAR |
| May 2, 2023 | 10-Q | 0000875320-23-000012 | View on SEC EDGAR |
| Feb 10, 2023 | 10-K | 0000875320-23-000007 | View on SEC EDGAR |
| Oct 28, 2022 | 10-Q | 0000875320-22-000038 | View on SEC EDGAR |
| Aug 5, 2022 | 10-Q | 0000875320-22-000030 | View on SEC EDGAR |
| May 6, 2022 | 10-Q | 0000875320-22-000014 | View on SEC EDGAR |
| Feb 9, 2022 | 10-K | 0000875320-22-000007 | View on SEC EDGAR |
| Nov 3, 2021 | 10-Q | 0000875320-21-000033 | View on SEC EDGAR |
| Jul 30, 2021 | 10-Q | 0000875320-21-000027 | View on SEC EDGAR |
| Apr 30, 2021 | 10-Q | 0000875320-21-000015 | View on SEC EDGAR |
| Feb 11, 2021 | 10-K | 0000875320-21-000006 | View on SEC EDGAR |
| Oct 30, 2020 | 10-Q | 0000875320-20-000043 | View on SEC EDGAR |
| Jul 31, 2020 | 10-Q | 0000875320-20-000030 | View on SEC EDGAR |
| May 1, 2020 | 10-Q | 0000875320-20-000019 | View on SEC EDGAR |
| Feb 13, 2020 | 10-K | 0000875320-20-000007 | View on SEC EDGAR |
| Oct 31, 2019 | 10-Q | 0000875320-19-000057 | View on SEC EDGAR |
| Aug 1, 2019 | 10-Q | 0000875320-19-000037 | View on SEC EDGAR |
| May 1, 2019 | 10-Q | 0000875320-19-000019 | View on SEC EDGAR |
| Feb 13, 2019 | 10-K | 0000875320-19-000006 | View on SEC EDGAR |
| Oct 25, 2018 | 10-Q | 0000875320-18-000029 | View on SEC EDGAR |
| Jul 26, 2018 | 10-Q | 0000875320-18-000022 | View on SEC EDGAR |
| Apr 27, 2018 | 10-Q | 0000875320-18-000014 | View on SEC EDGAR |
| Feb 15, 2018 | 10-K | 0000875320-18-000009 | View on SEC EDGAR |
| Oct 30, 2017 | 10-Q | 0000875320-17-000060 | View on SEC EDGAR |
| Jul 28, 2017 | 10-Q | 0000875320-17-000047 | View on SEC EDGAR |
| Apr 28, 2017 | 10-Q | 0000875320-17-000030 | View on SEC EDGAR |
| Feb 23, 2017 | 10-K | 0000875320-17-000017 | View on SEC EDGAR |
| Oct 31, 2016 | 10-Q | 0000875320-16-000107 | View on SEC EDGAR |
| Aug 1, 2016 | 10-Q | 0000875320-16-000091 | View on SEC EDGAR |
| May 3, 2016 | 10-Q | 0000875320-16-000078 | View on SEC EDGAR |
| Feb 16, 2016 | 10-K | 0000875320-16-000067 | View on SEC EDGAR |
| Oct 30, 2015 | 10-Q | 0000875320-15-000056 | View on SEC EDGAR |
| Aug 4, 2015 | 10-Q | 0000875320-15-000047 | View on SEC EDGAR |
| May 4, 2015 | 10-Q | 0000875320-15-000029 | View on SEC EDGAR |
| Feb 13, 2015 | 10-K | 0000875320-15-000012 | View on SEC EDGAR |
| Nov 6, 2014 | 10-Q | 0000875320-14-000063 | View on SEC EDGAR |
| Jul 31, 2014 | 10-Q | 0000875320-14-000058 | View on SEC EDGAR |
| May 5, 2014 | 10-Q | 0000875320-14-000026 | View on SEC EDGAR |
| Feb 11, 2014 | 10-K | 0000875320-14-000015 | View on SEC EDGAR |
| Nov 7, 2013 | 10-Q | 0000875320-13-000045 | View on SEC EDGAR |
| Aug 2, 2013 | 10-Q | 0000875320-13-000038 | View on SEC EDGAR |
| May 8, 2013 | 10-Q | 0000875320-13-000024 | View on SEC EDGAR |
| Mar 1, 2013 | 10-K | 0000875320-13-000009 | View on SEC EDGAR |
| Nov 6, 2012 | 10-Q | 0001047469-12-010125 | View on SEC EDGAR |
| Aug 8, 2012 | 10-Q | 0001047469-12-007979 | View on SEC EDGAR |
| May 10, 2012 | 10-Q | 0001047469-12-005755 | View on SEC EDGAR |
| Feb 22, 2012 | 10-K | 0001047469-12-001298 | View on SEC EDGAR |
| Nov 3, 2011 | 10-Q | 0001047469-11-009007 | View on SEC EDGAR |
| Aug 9, 2011 | 10-Q | 0001047469-11-007153 | View on SEC EDGAR |
| May 6, 2011 | 10-Q | 0001047469-11-004721 | View on SEC EDGAR |
| Feb 17, 2011 | 10-K | 0001047469-11-001025 | View on SEC EDGAR |
| Oct 28, 2010 | 10-Q | 0001047469-10-008963 | View on SEC EDGAR |
| Aug 3, 2010 | 10-Q | 0001047469-10-006916 | View on SEC EDGAR |
| May 3, 2010 | 10-Q | 0001047469-10-004633 | View on SEC EDGAR |
This list covers filings that contain XBRL financial data (generally from 2009 onward). It does not include 8-Ks, proxy statements or other forms. For the complete history, see Vertex Pharmaceuticals Inc. on EDGAR.
Source: SEC EDGAR XBRL company facts for CIK 875320 (raw data). Most recent filing in this dataset: 10-Q filed Nov 3, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.